I.M.Sechenov First Moscow State Medical University Russia
Sergey Suchkov graduated from Astrakhan State Medical University and awarded with MD, then in 1985 maintained his PhD at the I.M. Sechenov Moscow Medical Academy and in 2001, maintained his Doctorship Degree at the Nat Inst of Immunology, Russia. From 1987 through 1989, he was a senior Researcher, Kolt-zov Inst of Developmental Biology. From 1989 through 1995, he was a Head of the Lab of Clinical Immunology, Helmholtz Eye Research Institute in Moscow. From 1995 through 2004, a Chair of the Dept for Clinical Immunology, Moscow Clinical Research Institute (MONIKI.DrSuchkov has been trained at: NIH; Wills Eye Hospital, PA, USA; Univ of Florida in Gainesville; UCSF, S-F, CA, USA; Johns Hopkins University, Baltimore, MD, USA. He was an Exe Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK. At present, Dr Sergey Suchkov is a Chair, Dept for Personalized and Translational Medicine, I.M.Sechenov First Moscow State Medical University. He is a member of the: New York Academy of Sciences, USA; American Chemical Society (ACS), USA; American Heart Association (AHA), USA; EPMA (European Association for Pre-dictive, Preventive and Personalized Medicine), Brussels, EU; ARVO (American Association for Research in Vision and Ophthalmology); ISER (International Society for Eye Research); PMC (Personalized Medicine Coalition), Washington, USA.
Dr Gamlen has had an extensive career spanning over 40 years in scientific research and tablet development in a range of contexts including Development, Clinical Trials Manufacturing and Production. Formally the Head of Tablet Development at the Wellcome Foundation Ltd for 15 years, and a consultant to Vanguard Medical Ltd, Michael recognised and identified the need to improve tablet quality under controlled laboratory conditions.
An excellent communicator, Michael has an international reputation as a presenter and speaker on tableting, process development and related technical areas. An honorary lecturer at De Montford University School of Pharmacy, he also acts as a Pharmaceutical Expert Witness in a broad range of pharmaceutical cases relating to drug substance properties, tablet formulation and development, and controlled release product development.
Dr. Anne Sapin-Minetis an Associate Professor in Pharmaceutical Technologiesin Nancy, France (research unit EA 3452 CITHEFOR). She has over 12 years experience in teaching conventional and innovative drug delivery systems in University of Lorraine. She is author of more than 20 papers published mainly on international journals.Currently, Dr. Anne Sapin-Minet is engaged in working on the development of new therapeutic strategies for Nitric Oxide donor delivery (mainly in the context of vascular pathologies). Control of the release of NO is optimized, depending on the route of administration, using particulate formulations (nano or micro).
Dr. Michael J. Gonzalez is Professor at the Nutrition Program, School of Public Health in the Medical Sciences Campus, University of Puerto Rico and Adjunct faculty at the University of Western States And EDP University. Dr. Gonzalez is a Fellow of the American College of Nutrition, and has authored over 200 scientific publications. He serves as a member on multiple scientific Editorial Boards. He has served as consultant for several companies where he has been responsible for designing formulations of nutritional supplements and pharmaceutical products. He has also been a consultant for The Center for the Improvement of Human Functioning (now Riordan Clinic), in Wichita, Kansas. He has obtained several research awards for his work on Nutrition and Cancer. He is currently Co- Director of RECNAC II project, and Research Director of the InBioMed Project Initiative. Dr. Gonzalez also serves as a nutrition consultant to the Puerto Rican Basketball National Team and is part of the Medical Commission of the Puerto Rican Basketball Federation. He was part of the Medical Staff of the Vaqueros de Bayamon professional basketball team in Purto Rico. He is in a part time clinical practice with Dr. Miguel J Berdiel in Ponce, PR. In December 2013,Dr. Gonzalez was exalted as Distinguished Ponceño in Medicine. In 2015 he was selected as member to the prestigious Puerto Rican Academy of Arts and Sciences and to the Iberoamerican Academy of Culture and Sciences.
Doctor González is one of the founders of InBioMed, leaders in the development of non-toxic chemotherapy treatments for cancer. The findings of their work with Intravenous Vitamin C as an anti-cancer agent, published in 2002, were confirmed by the NIH in 2005. They published the first Phase-I clinical study utilizing Intravenous Vitamin C for treatment of terminal cancer patients in 2005, and also published in 2005 the most comprehensive review on Vitamin C and Cancer, as a follow-up on the work of two times Nobel Laureate, Dr. Linus C. Pauling. They have brought many new concepts into the scientific field, such as the Bioenergetic theory of carcinogenesis, the systemic saturation phenomenon of intravenous vitamin C, the metabolic correction concept for disease treatment and prevention. Dr. Gonzalez was inducted to the International Hall of fame of Orthomolecular Medicine April, 2016. He is one of the first hispanoamerican and Puerto Rican to be inducted to the International Hall of fame of Orthomolecular Medicine.
Books: “I Have Cancer What Should I do: The Orthomolecular Guide to Cancer Management” provides evidence based recommendations for an integrative approach for those dealing with cancer and seeking to improve quality of life and survival. In 2014 ” New Insights Vitamin C and Cancer” a book on the scientific evidence on Vitamin C as an anticancer agent for Springer-Larger. Dr. Gonzalez is actually finishing a book on Metabolic Correction and Diabetes and writing a chapter on metabolic correction and disease for a Functional medicine textbook.
With Seetharaman.r Application of Chemometrics and Experimental design for the estimation of antihypertensives, antidiabetics and their combinations
With Kavitha .J ï¿½Application of Multivariate Calibration for the estimation of harmful ingredients present in Food, Cosmetics and Pharmaceuticals causing infertility
Work in Progress:
Mr.R. Seetharaman : Application of Chemometrics and Experimental design for the estimation of cardiovascular and Antidiabetic Drugs.
Mr. K. Manikandan : Chemometric applications for Estimation of novel drugs and its combinations.
Mrs. J. Kavitha : Application of chemo metrics and experimental design for the estimation of Harmful agent causing infertility in foods and cosmetics and pharmaceuticals.
Mrs. J. Jayasutha : Evaluation of efficacy, safety and cost effectiveness of various combination therapy in hyperinsulinemic polycystic ovary syndome.
Mrs. K.S. Koilambiga : Design, Development and Validation of HPLC and HPTLC method for the novel drug combinations.
Mr. V.J. Vishu Varathan : A Comparative study on the therapeutic effect of formononetin and formononetin loaded solid lipid nanoparticles in the treatment of lung cancer
Mrs.M.Rama : Attenuation of PCOS ï¿½ Polycycstic ovarian syndrome using Herbal Formulation in rat model
Taught UG, PG grades in Pharmacy for 22 years.
Currently as Dean cum Head Of Department of Pharmaceutical Analysis, SRM College of Pharmacy, SRM Institute of Science and Technology (formerly known as SRM University)- India. website www.srmuniv.ac.in.
Other Professional Experience:
As a Dean of SRM Pharmacy College, SRM Institute of Science and Technology (formerly known as SRM University) India, for the past 20 years.1996-Till date
Served as a Principal with Velï¿½s College of Pharmacy, The Tamil Nadu Dr. MGR Medical University, Chennai, India for four years.1992-1996
Lecturer at CLBM College of Pharmacy Chennai Tamil Nadu India 1990-1992.
First Assignment as Lecturer at JSS College of Pharmacy Ooty Tamil Nadu India 1988-1990.
Key responsibilities included program development and annual program funding allocation.
Doctorial Committee - 3 Universities
Achievements and Awards:
Inspector for the Pharmacy Council of India, New Delhi ï¿½ India.
Inspector for the Tamil Nadu DR.M.G.R Medical University , Chennai ï¿½ India.
Professor Yong Zhang has completed his PhD from Harbin Medical University, China and postdoctoral studies from University of Connecticut, USA. He is the dean of School of Pharmacy, Harbin Medical University. He has published more than 60 papers in SCI journals such as Nature Communications, Circulation Research, Pharmacology & Therapeutics, British Journal of Pharmacology, etc. He has been serving as an editorial board member of Engineering, Frontiers of Medicine.
Safiye Emirdag-Ozturk is an associate professor at Ege University. She was graduated M.Sc degree which was about dissertation "Chemical structural analysis of knautiaintegrifoliarootsâ€ in 2002. At 2008, her Ph.D. dissertation was â€œSynthesis of some benz of urans and their activitiesâ€. After then, she did post-doctorate at Hohenheim University and worked about greenchemistry which is her research publication â€œLaccase-catalyzed reaction of 3-tert-butyl-1H-pyrazol-5(4H)-one with substituted catecholsusingair as an oxidantâ€. As a result of her theses and researches, She is the author of many research papers published mainly on international journals her publications such as Tetrahedron:Laccase-catalyzedreaction of 3-tert-butyl-1H-pyrazol-5(4H)-one with substituted catecholsusingair as an oxidant, European Journal of Medicinal Chemistry :Synthesis, anti microbial and cytotoxic activities, and structure-activity relationships of gypsogen inderivatives against human cancer cells; Synthesis and study of cytotoxic activity of 1,2,4-trioxane- and egonol-derivedhybrid molecules against Plasmodium falci parumand multidrug-resistant human leukemia cells, Bio organic Chemistry:Synthesis, characterization and in vitro anti-neoplastic activity of gypsogen inderivatives, Bio organic & Medicinal Chemistry:Synthesis of egonol derivatives and their anti microbial activities, Biological & Pharmaceutical Bulletin:The First Pentacyclic Triterpenoid Gypsogen in Derivative Exhibiting Anti-ABL1 Kinase and Anti-chronic Myelogenous Leukemia Activities. Her research interests include organic chemistry, medicinal chemistry, green chemistry, natural compounds chemistry, chromatography, and bioorganic chemistry. In addition to her studies as a researcher, she worked as a project manager many times (TUBÄ°TAK Projects).Currently, the Turkish-Japanes ebilateral cooperation project(TheScientific and Technological Research Council of Turkey TÃœBÄ°TAK- Japan Society for Promotion of Science) is continuing. As part of this project, she went to Kumamoto University in Japan for research. In addition to the projects carried out, she was the editor of an international multi disciplinary workshop and many congress sessions as chairperson.
she is a regular teacher of): Pharmaceutical Technology, Socioeconomy and Law for Industrial Pharmacy degree (II level), University of Perugia (Dept. of Pharmaceutical Sciences)
Previous teaching: Pharmaceutical industrial processes and equipments, Pharmaceutical Technology for Industrial Pharmacy course (II level) and Quality Control course (Ilevel).
Cosmetic Products for Enviromental and Occupational Prevention Techniques course (I level) Biotech Production for Biotechnology course (I level)
She is director and didactic coordinator for II level master (post graduation) in Pharmaceutical Technology and Regulatory Affairs.
She is a member of the teaching board of international and industrial doctorate (Ph. D. Course) in Pharmaceutical Sciences, university of Perugia (Italy).
She graduated in Pharmacy in 1986 and obtained her Ph.D. graduation in 1992. She is author of many research papers (more than 150) published mainly on international journals.
She was a member of Bioethic Committee of the University of Perugia and Arezzo Hospital.
She founded an university spin off in 2008 for production and studies of nanomaterials for pharmaceutical and cosmetic products.
Stefania Galdiero earned her PhD in Chemistry in the field of peptides at the University of Naples ‘‘Federico II’’ in 1998. She carried out research activities at the Columbia University of New York in 1996-97. In 1999 she earned the position of lecturer in Inorganic Chemistry at the University of Naples and from 2012 to 2018 she has been Adjunct Professor at Loyola University Chicago. Since 2015 she is Associate Professor of Inorganic Chemistry. Recent research activities focus on antimicrobial peptides and mechanisms of drug intracellular delivery for cancer. Elucidating the principles that govern the protein/membrane interactions and understanding the molecular forces underlying peptide-peptide interactions within the lipid environment of the cell membrane are major goals. She is author of more than 100 publications in international scientific journals.
Fabienne Gourand obtained her PhD in Chemistry in the field of
radiochemistry at the University of Caen. She is a researcher at the
Laboratory of Methodological Developments for Positron Emission
Tomography (LDM-TEP team) at Cyceron Center in Caen.
Research activities focus on the development of radiotracers (using
Carbon-11 and Fluorine-18 radiochemistry) and their in vivo
evaluation to determine their potential interest for Positron Emission
Tomography (PET) imaging. Some of the radiotracers donâ€™t cross the
BBB (blood brain barrier) and their transport into the central nervous
system has been studied thanks to a chemical delivery system (CDS)
based on a redox system dihydroquinoline/ quinolinium salt.
Cinzia Pagano received her Ph.D. in Chemistry and Pharmaceutical Technology in 2011 at the University of Perugia. She is Researcher at Department of Pharmaceutical Sciences (University of Perugia, Italy) and teach Pharmaceutical Technology, Socio-Economy and Law for the course of Pharmacy degree (II level). Recent research activity focuses on the development and characterization of polymeric bioadhesive formulations for wounds treatment and on the use of active ingredients coming from natural sources. She published more than 30 research articles in pharmaceutical technology field in international scientific journals and she is co-inventor of one patented nutraceutical product actually available on the market.
My career path was initiated by taking my PhD in London at UCL on the topic Screening of protein-protein and protein-ligand interaction using Mass Spectrometry. My path took me to Ghent University where I worked as Scientific Research Manager, and then at VIB in a combined project with Roche. I then moved to Clinical Project Manager phase I at Pfizer, in Belgium, and currently, I work as a Senior Clinical Research Manager at BIAL, where I continue my work in phase I clinical trials.
Ana Henriques Mota is doing her Ph.D. programme in Pharmaceutical Technology at Faculdade de Farmácia, Universidade de Lisboa, Lisbon, Portugal, under super vision of Professor Catarina Pinto Reis, Professor António José Almeida and Professor Elias Fattal. In 2015, she received the M.S. degree in Pharmaceutical Sciences from Universidade Lusófona de Humanidades e Tecnologias, Lisbon, Portugal. In 2014, she did a Research Internship at the Faculté de Pharmacie, Université de Lorraine, Nancy, France, under supervision of Professor Philippe Maincent. From 2016 to 2017, she was Assistant Professor in Pharmaceutical Technology at the School of Sciences and Health Technologies at Universidade Lusófona de Humanidades e Tecnologias, Lisbon, Portugal. She is author of four articles. Her research interests include nanotechnology, in vitro and in vivo assays.
Raquel Pereira da Silva
Faculty of Medicine of the University of Porto Portugal
Faculty of Medicine of the University of Porto Portugal
Raquel Silva has a Bachelors degree in Pathologic Anatomy obtained in 2009 by the School of Allied Health Sciences of Porto and an Integrated Masters degree in Pharmaceutical Sciences achieved in 2014 at Fernando Pessoa University in Porto, Portugal. Currently, she is attending the International Doctoral Program in Neuroscience of the University of Porto and performing research at the Faculty of Medicine of the University of Porto and the Institute for Innovation and Health Research with research focused on understanding the role of the monoaminergic systems on the descending and affective modulation of pain and on pain-induced emotional comorbidities.
Rebecca McVicker became Product Director at Gamlen Instruments Ltd. in 2019. Prior to that she spent three years as a Materials Scientist at GSK specilaising in oral solid dose formulations. She completed her PhD in catalytic materials at Cardiff University in 2014 where she spent the following year working as a post-doctoral researcher on a project funded by Exxon Mobil. She has a BSc in Chemistry from the National University of Ireland, Galway.
Claudia Pina Costa is a Master in Pharmaceutical Sciences since 2016. Currently, she is
a PhD Scholarship Student in Pharmaceutical Technology at the Faculty of Pharmacy of
the University of Porto, Porto, Portugal.
Her research work is focused on the development of lipid nanoparticles-based
formulations for nose-to-brain delivery of antiepileptics. She is author and co-author of
two publications in peer-reviewed journals, 1 book chapter, 2 oral communications, and
4 posters presented at international scientific conferences
Mohamed Radwan is an Associate/Owner at Shoppers Drug Mart in Calgary/AB, Canada; He is a PharmD Candidate-University of Toronto. Mohamed is an Instructor at Bredin Institute for learning in Calgary where he teaches Canadian regulations and Pharmacy Management for international Pharmacy graduates.
Mohamed has more than 15 years of progressive experience diversified in different styles of pharmacy practice in different countries between Community Pharmacies and Pharmaceutical industry with a wide range of exposure to multiple cultures of Health Care Professionals.
Mohamed believes that the ClinicalPharmacist should go beyond the scope of just checking the prescriptions and dispensing the right medications but should be involved in a Comprehensive Clinical Care Plans for the patients.
Carolina S.Vinagreiro is a Medicinal Chemistry PhD student. In 2015, she has completed her Msc from Coimbra University with a final grade of 19/20 , on Mariette M. Pereira supervision. Carolina Vinagreiro ranked first among her classmates and was awarded various prizes as the best student in high school (18.4/20), in the BSc (17/20) and in the MSc (19/20). Her outstanding performance was reward by 14 awards received. From the scientific research developed, five scientific papers and 1 chapter has already published and 2 patents was submitted. Moreover, she is author of 15 oral communications, two of which with prize for best oral communication and several posters.
Juwairiya Butt corresponding author of this paper has completed her MPhill degree in Pharmacy (Pharmacognosy) from Punjab University College of Pharmacy, Lahore , Pakistan. Now will take admission in Phd this year in computational phytochemistry in Liverpool John Moores University, UK. Currently working as an assisstant professor in Faculty of Pharmacy, The University of Lahore, Lahore, Pakistan. She is having seven publications in well reputed journals. She always work on new ideas like , Translational Research rolls, Drug –Poison enigma, Molecular techniques applications on alternative medicine.